These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25086834)

  • 1. Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort.
    Unger JA; Richardson BA; Otieno PA; Farquhar C; Wamalwa D; John-Stewart GC
    BMC Pregnancy Childbirth; 2014 Aug; 14():257. PubMed ID: 25086834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.
    Richardson BA; Otieno PA; Mbori-Ngacha D; Overbaugh J; Farquhar C; John-Stewart GC
    AIDS; 2007 Mar; 21(6):749-53. PubMed ID: 17413696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality.
    Otieno PA; Brown ER; Mbori-Ngacha DA; Nduati RW; Farquhar C; Obimbo EM; Bosire RK; Emery S; Overbaugh J; Richardson BA; John-Stewart GC
    J Infect Dis; 2007 Jan; 195(2):220-9. PubMed ID: 17191167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study.
    Navas-Nacher EL; Read JS; Leighty RM; Tuomala RE; Zorrilla CD; Landesman S; Rosenblatt H; Hershow RC;
    AIDS; 2006 Feb; 20(3):429-36. PubMed ID: 16439877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
    Roxby AC; Drake AL; Ongecha-Owuor F; Kiarie JN; Richardson B; Matemo DN; Overbaugh J; Emery S; John-Stewart GC; Wald A; Farquhar C
    PLoS One; 2012; 7(6):e38622. PubMed ID: 22701683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of HIV disease among women following delivery.
    Watts DH; Lambert J; Stiehm ER; Harris DR; Bethel J; Mofenson L; Meyer WA; Mathieson B; Fowler MG; Nemo G;
    J Acquir Immune Defic Syndr; 2003 Aug; 33(5):585-93. PubMed ID: 12902802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study.
    Read JS; Tuomala R; Kpamegan E; Zorrilla C; Landesman S; Brown G; Vajaranant M; Hammill H; Thompson B;
    J Acquir Immune Defic Syndr; 2001 Mar; 26(3):236-45. PubMed ID: 11242196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
    Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
    BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
    Ekpini RA; Nkengasong JN; Sibailly T; Maurice C; Adjé C; Monga BB; Roels TH; Greenberg AE; Wiktor SZ
    AIDS; 2002 Mar; 16(4):625-30. PubMed ID: 11873007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
    Phillips AN; Eron JJ; Bartlett JA; Rubin M; Johnson J; Price S; Self P; Hill AM
    AIDS; 1996 Jul; 10(8):859-65. PubMed ID: 8828743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
    AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.
    Brown ER; Otieno P; Mbori-Ngacha DA; Farquhar C; Obimbo EM; Nduati R; Overbaugh J; John-Stewart GC
    J Infect Dis; 2009 May; 199(9):1292-300. PubMed ID: 19317628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
    Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
    East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
    Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
    BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
    Demeter LM; Hughes MD; Coombs RW; Jackson JB; Grimes JM; Bosch RJ; Fiscus SA; Spector SA; Squires KE; Fischl MA; Hammer SM
    Ann Intern Med; 2001 Dec; 135(11):954-64. PubMed ID: 11730396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.